Sort
261,768 grants matching “gene therapy”
Growth-Differentiation Factors in Organogenesis
$981,912Alan Perantoni · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy
$981,896Irving Lerner Weissman · Stanford University · R35 · FY2019 · CA
Commercialization of PANDAA qDx for rapid drug resistance genotyping of protease inhibitor ART failures in resource-limited settings.
$981,812Iain James Macleod · Aldatu Biosciences, Inc. · SB1 · FY2023 · AI
Endocrine Responsiveness and Cellular Stress
$981,668Robert R. Clarke · Georgetown University · U54 · FY2013 · CA
PTEN and Cancer
$981,614Ramon E Parsons · Icahn School Of Medicine At Mount Sinai · R35 · FY2019 · CA
Neuropeptides and Carboxypeptidase E/ Neurotrophic Factor-1 in Neural and Cognitive Functions
$981,601Yoke Peng Loh · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2018 · HD
Severe Chronic Neutropenia International Registry
$981,464David Chandler Dale · University Of Washington · R24 · FY2019 · AI
Clinical development of mechanism-based lymphoma therapies
$981,462Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
A Therapeutic Vaccine for Chronic Hepatitis B
$981,428David R. Milich · Vlp Biotech, Inc. · R44 · FY2014 · AI
Genomic and Genomic Variation in Prostate Cancer
$981,414Timothy R Rebbeck · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Neuroprotective role of GLP-1 receptor agonists
$981,407Nigel H. Greig · National Institute On Aging · ZIA · FY2017 · AG
The Role of Transforming Growth Factor Beta (TGFbeta) in Promoting Allergic Inflammation
$981,321Pamela Guerrerio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Novel Diagnostic Sequencing System for HIV Resistance Testing
$981,200Jerzy Olejnik · Intelligent Bio-Systems, Inc. · R44 · FY2012 · AI
Development Of Theoretical Methods For Studying Biological Macromolecules
$981,192Bernard R Brooks · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
Optimization of novel pyranopyridine efflux pump inhibitors
$981,076Timothy J Opperman · Microbiotix, Inc · R44 · FY2020 · AI
Next Generation Smart Nanoparticles
$981,050Paul Alivisatos · Stanford University · U54 · FY2012 · CA
Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models
$980,619Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Arizona Center for Education and Research on Therapeutics
$980,536Raymond L Woosley · Critical Path Institute · U18 · FY2008 · HS
Social Determinants of Health as Transducers of Cellular Aging: A New Multi-level Paradigm to Reduce Survivorship Disparities at the Intersection of Cancer and Aging
$980,446Jeanne Mandelblatt · Georgetown University · R35 · FY2023 · CA
PredicTOR: predicting patient response to mTOR pathway inhibitors prior to treatm
$980,392John Gillespie · 20/20 Genesystems, Inc. · R44 · FY2012 · CA
Center for Systems Biology
$980,343Leroy E Hood · Institute For Systems Biology · P50 · FY2011 · GM
Gene Therapy for Urea Cycle Disorders
$980,295James M Wilson · University Of Pennsylvania · P01 · FY2009 · HD
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States
$980,283Pablo Tamayo · University Of California, San Diego · U01 · FY2019 · CA
CORE CENTER FOR GENE THERAPY
$980,282University Of Washington · P30 · FY2000 · DK
CORE CENTER FOR GENE THERAPY
$980,282University Of Washington · P30 · FY2001 · DK